nanoparticles

Scientists at Johns Hopkins used a whole-body imaging technique to track where therapeutic cells go after injection

The approach pairs ultrasound-induced tumor cell death with real-time antigen capture to drive both local and systemic immune responses.

A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.

Operational scale-up accelerates global growth strategy to increase regional access and technical support

Researchers designed a nanoparticle that inactivated a wide range of COVID-19 strains, potentially offering a broad-spectrum therapeutic approach.

Magnetic carbon nanotubes treat drug-resistant glioblastoma in mice, but hurdles remain for human translation.

Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops and pills are on their way.

Researchers simultaneously increased the potency of a cancer drug while reducing both the required dose and the side effects, all by using a surprising new drug delivery vehicle: bacteria.

Join a panel of experts as they discuss nanoparticle technology and key considerations for nanoparticle-based drug delivery.  

Nanoparticles fuse with cells to deliver their gene or RNA therapy cargo, but some are better shuttles than others. Now, scientists have developed a way to find the best nanoparticles for the job.